\
&
Contact us
This was 2 years ago
Locationvirtual
ProgrammesThe European Research Council Proof of Concept Grants (PoC) aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to ERC Principal Investigators (PIs) whose proposals draw substantially on their ERC funded research.
European Innovation Council (EIC) Transition aims to validate and demonstrate technology in an application relevant environment and develop market readiness. It supports both the maturation and validation of technologies from lab to real environment. EIC Transition proposals must build on the results from
The webinar will present both funding schemes.
Programme
The webinar is organized by Access2EIC, the network of the EIC and European Innovation Ecosystems (EIE) National Contact Points. Registration is required via the registration form in the announcement
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.